Search Results - "Leite, L.C.C"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Recombinant vaccines and the development of new vaccine strategies by Nascimento, I P, Leite, L C C

    “…Vaccines were initially developed on an empirical basis, relying mostly on attenuation or inactivation of pathogens. Advances in immunology, molecular biology,…”
    Get full text
    Journal Article
  2. 2

    The long search for a serotype independent pneumococcal vaccine by Converso, T R, Assoni, L, André, G O, Darrieux, M, Leite, L C C

    Published in Expert review of vaccines (02-01-2020)
    “…: Serotype replacement - a consequence of polysaccharide vaccine use - will continue to drive the inclusion of new serotypes on conjugate vaccines, increasing…”
    Get more information
    Journal Article
  3. 3

    Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice by Converso, T.R, Goulart, C, Rodriguez, D, Darrieux, M, Leite, L.C.C

    Published in Vaccine (03-01-2017)
    “…Abstract Streptococcus pneumoniae (pneumococcus) is a human pathogen that can cause otitis media, pneumonia and, in severe cases, meningitis and bacteremia…”
    Get full text
    Journal Article
  4. 4

    Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing by André, G.O., Politano, W.R., Mirza, S., Converso, T.R., Ferraz, L.F.C., Leite, L.C.C., Darrieux, M.

    Published in Microbial pathogenesis (01-12-2015)
    “…Streptococcus pneumoniae is a common colonizer of the human nasopharynx, which can occasionally spread to sterile sites, causing diseases such as otitis media,…”
    Get full text
    Journal Article
  5. 5

    Schistosoma mansoni: Molecular characterization of Alkaline Phosphatase and expression patterns across life cycle stages by Araujo-Montoya, B.O., Rofatto, H.K., Tararam, C.A., Farias, L.P., Oliveira, K.C., Verjovski-Almeida, S., Wilson, R.A., Leite, L.C.C.

    Published in Experimental parasitology (01-11-2011)
    “…[Display omitted] ► Complete molecular analysis of Schistosoma mansoni Alkaline Phosphatase cDNA gene. ► Transcriptional analysis and expression profile of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Recombinant vaccines and the development of new vaccine strategies by I.P. Nascimento, L.C.C. Leite

    “…Vaccines were initially developed on an empirical basis, relying mostly on attenuation or inactivation of pathogens. Advances in immunology, molecular biology,…”
    Get full text
    Journal Article
  8. 8

    A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice by Converso, T.R., Goulart, C., Darrieux, M., Leite, L.C.C.

    Published in Vaccine (12-09-2017)
    “…Despite the success of the available polysaccharide-based vaccines against Streptococcus pneumoniae in preventing invasive diseases, this bacterium remains a…”
    Get full text
    Journal Article
  9. 9

    Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines by Converso, T.R., Goulart, C., Rodriguez, D., Darrieux, M., Leite, L.C.C.

    Published in Microbial pathogenesis (01-08-2017)
    “…Pneumococcal surface protein A (PspA) is a widely studied pneumococcal protein, exposed at the surface of all strains. It is an important virulence factor,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Fusion Proteins Containing Family 1 and Family 2 PspA Fragments Elicit Protection against Streptococcus pneumoniae That Correlates with Antibody-Mediated Enhancement of Complement Deposition by Darrieux, M, Miyaji, E.N, Ferreira, D.M, Lopes, L.M, Lopes, A.P.Y, Ren, B, Briles, D.E, Hollingshead, S.K, Leite, L.C.C

    Published in Infection and Immunity (01-12-2007)
    “…PspA is an important pneumococcal vaccine candidate that is capable of inducing protection in different animal models. Because of its structural diversity, a…”
    Get full text
    Journal Article
  12. 12

    Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis by Gamberini, Marcia, Gómez, Ricardo M., Atzingen, Marina V., Martins, Elizabeth A.L., Vasconcellos, Silvio A., Romero, Eliete C., Leite, Luciana C.C., Ho, Paulo L., Nascimento, Ana L.T.O.

    Published in FEMS microbiology letters (15-03-2005)
    “…Leptospirosis is an important global human and veterinary health problem. Humans can be infected by exposure to chronically infected animals and their…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Purification of meningococcal group C polysaccharide by a procedure suitable for scale-up by Tanizaki, Martha M., Garcia, Ligiane R., Ramos, Julia B., Leite, Luciana C.C., Hiss, Haroldo, Furuta, Joana A., Cabrera-Crespo, Joaquin, Raw, Isaias

    “…Neisseria meningitidis group C capsular polysaccharide is the antigen for the vaccine. An easier method has been developed for the purification of N…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Platelet activating factor, an endogenous mediator of inflammation, induces phenotypic transformation of rat embryo cells by Bennett, S A, Leite, L C, Birnboim, H C

    Published in Carcinogenesis (New York) (01-07-1993)
    “…The ability of platelet activating factor (PAF), a potent endogenous inflammatory agent, to induce phenotypic transformation of primary rat embryo cells (RECs)…”
    Get more information
    Journal Article